Back to results

CompletedPhase 2

Mechanistic Evaluation of Response in TRD (MERIT)

NCT04608396

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Clinical Research Site

Little Rock, Arkansas, United States

+19 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2020-08-13
Enrollment: 44 participants
Sponsor: Axsome Therapeutics, Inc.
Purpose: treatment

Locations (20)

Clinical Research SiteLittle Rock, Arkansas, United States
Clinical Research SiteRedlands, California, United States
Clinical Research SiteSherman Oaks, California, United States
Clinical Research SiteUpland, California, United States
Clinical Research SiteMiami, Florida, United States
Clinical Research SiteNorth Miami, Florida, United States
Clinical Research SiteOrlando, Florida, United States
Clinical Research SiteChicago, Illinois, United States
Clinical Research SiteBoston, Massachusetts, United States
Clinical Research SiteBerlin, New Jersey, United States
Clinical Research SiteRochester, New York, United States
Clinical Research SiteStaten Island, New York, United States
Clinical Research SiteHickory, North Carolina, United States
Clinical Research SiteRaleigh, North Carolina, United States
Clinical Research SiteCincinnati, Ohio, United States
Clinical Research SiteMiddleburg Heights, Ohio, United States
Clinical Research SiteMedia, Pennsylvania, United States
Clinical Research SiteDallas, Texas, United States
Clinical Research SiteHouston, Texas, United States
Clinical Research SiteEverett, Washington, United States

Mechanistic Evaluation of Response in TRD (MERIT) — TrialFind